Amphastar Pharma (AMPH) Tops Q1 EPS by 15c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.12, $0.15 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $59.4 million versus the consensus estimate of $62 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Morgan Stanley upgrades CDW on stronger AI-driven server demand